​6 superstar investors, 6 big bets of Madhusudan Kela, Ashish Kacholia & others

Investors keenly watch out for market moves made by ace investors which mostly prove to beat the overall stock market volatility. Here are the top stock holdings of ace investors Radhakishan Damani, Ashish Kacholia, Madhusudan Kela, Vijay Kedia, Mukul Agrawal and Dolly Khanna.

DMart founder and market veteran Radhakishan Damani is among India's richest stock market investors, with his family's net worth estimated at over $28 billion, according to Forbes. Popularly known as the “retail king of India”, the billionaire publicly holds 12 stocks. While DMart-operator Avenue Supermarts officially is his top stock holding, he and his family acquired around a 2.4% stake in NBFC Sundaram Finance, worth Rs 1,239 crore, during the April-June quarter of FY27, according to Trendlyne data. The stock has gained over 2% in the past month but is down more than 11% in 2026 so far. It has gained around 80% in three years and over 85% in five years.

Ace investor Ashish Kacholia is closely tracked for his stock picks. Often called the 'Big Whale' of the Indian stock market, Kacholia publicly holds around 48 stocks worth nearly Rs 3,229 crore, according to Trendlyne data. Shaily Engineering Plastics remains Ashish Kacholia’s largest holding in terms of value, as the ace investor owned more than 5% stake in the company worth around Rs 805 crore at the end of the April-June quarter of the ongoing financial year 2027, according to Trendlyne data. After hitting a 52-week low of Rs 1,770.90 apiece in April this year, the stock more than doubled in less than four months to hit a 52-week high of Rs 3,615.20 apiece last month. The stock has gained over 3% in one week and around 7% in one month, being overall up 51% in 2026 so far. In the longer term, the shares of the company jumped 96% in three years.
Also read | Ashish Kacholia's portfolio: How ace investor's top 5 stock holdings performed in one month?​

Madhusudan Kela publicly holds around 19 stocks worth nearly Rs 2,568 crore, according to Trendlyne data. Kela held more than 160 lakh shares, or a 7.2% stake, in broking firm Choice International at the end of the April-June quarter of FY27, according to NSE shareholding data. The stock fell more than 7% in August and 10% in 2026 so far. It has, however, delivered 267% returns over three years.

Ace investor Vijay Kedia is known for his investment acumen and market insights and is widely followed by investors on Dalal Street. Explaining his investment rationale, Kedia once said, “One should scout for companies which have good management. Find very good, very honest management and see the product in which the management is going to outperform its peers and the economy. Invest in those companies for the next 10-15 years, and you cannot go wrong.” Kedia held 1.3 lakh shares of active pharmaceutical ingredients (APIs) manufacturer Neuland Laboratories, worth Rs 309 crore, at the end of Q1 FY27, according to Trendlyne data. The stock has rallied 540% in three years and 1,303% in five years. It has also gained more than 57% in 2026 so far.
Also read | Exclusive | How Vijay Kedia turned a Rs 250 Neuland Labs bet into nearly 100x returns​

Mukul Agrawal publicly holds 72 stocks with a net worth of more than Rs 8,196 crore. Like Vijay Kedia, Neuland Laboratories is Mukhul Agrawal’s top stock holding as well. He owned 3% stake or 4 lakh shares of the company at the end of the April-June quarter of FY27.

Dolly Khanna is a Chennai based large investor, whose portfolio is managed by her husband Rajiv Khanna. She publicly holds three stocks with a net worth of more than Rs 328 crore. Chennai Petroleum accounts for most of her portfolio, as the ace investor held 1.2% stake or nearly 19 lakh shares in the company as at the end of the April-June quarter of FY27. The multibagger stock has jumped 108% in one year and 205% in three years, rallying over 72% in 2026 so far and more than 1,210% in five years.
Disclosure: This article has been written by Debaroti Adhikary, who is not a SEBI-registered Research Analyst or an Investment Adviser. Debaroti Adhikary and her ‘relative(s)’ (as defined under Section 2(77) of the Companies Act, 2013) do not hold any financial interest in the companies mentioned in this article as of the date of publication. The views/recommendations mentioned in this article, wherever applicable, are those of the respective SEBI-registered Research Analyst/brokerage and have been reproduced/reported with due attribution. They should not be construed as the views or recommendations of The Economic Times Digital or the journalist. Readers are advised to consider the original research report and make their investment decisions based on their own assessment. Brokerage disclaimers here